More information regarding the next edition of NCHIV will be announced in the course of 2023.
Programme 2022
| 08:00 | Registration | |
|---|---|---|
| 09:00 - 09:10 | Opening and introductions | Board stichting NCHIV |
| SESSION 1 | Innovations in Treatment, Vaccines and Cure | |
| Chairs: Monique Nijhuis (UMC Utrecht) and Bram Goorhuis (Amsterdam UMC) | ||
| 09:10 - 09:35 | Plenary: Antibody-based treatments for HIV | Marina Caskey (The Rockefeller University, New York) |
| 09:35 - 09:50 | Moderated Q&A | |
| 09:50 - 10:00 | O.01: Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination | Marlou Jongkees (Erasmus MC) |
| 10:00 - 10:10 | O.02: HIV-infected people in West-Kenya at higher risk of SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-related hospitalizations: Implications for COVID-19 vaccine prioritization in people living with HIV in Kenya | Patricia Gómez-Pérez (PharmAccess Foundation) |
| 10:10 - 10:20 | O.03: HIV-1 3’-polypurine tract mutations confer dolutegravir resistance by switching to an integration-independent replication mechanism via 1-LTR circles | José Dekker (Amsterdam UMC) |
| 10:20 - 10:30 | O.04: The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy | Henrieke Prins (Erasmus MC) |
| 10:30 - 10:55 | Refreshment break | |
| SESSION 2 | Barriers to Testing, Removing the HIV Reservoir, and Reducing Transmission | |
| Chairs: Maarten Schim van der Loeff (GGD Amsterdam) and Godelieve de Bree (Amsterdam UMC) | ||
| 10:55 - 11:05 | O.05: Evaluating the implementation of home-based sexual health care among men who have sex with men using the RE-AIM framework | Hanneke Goense (Maastricht University, GGD Zuid Limburg) |
| 11:05 - 11:15 | O.06: HIV teams as a tool to improve HIV indicator condition-guided testing: the necessity of being aware | Carlijn Jordans (Erasmus MC) |
| 11:15 - 11:25 | O.07: CRISPR-Cas attack on the HIV-1 provirus can cause unintended deletion of surrounding cellular DNA | Ye Liu (Amsterdam UMC) |
| 11:25 - 11:35 | O.08: Detection of Intact HIV proviral DNA in the CNS of a virally suppressed HIV-infected individual | Marieke Nühn (UMC Utrecht) |
| 11:35 - 11:45 | O.09: Transmission of (drug resistant) HIV between the Dutch Caribbean islands and the Netherlands | Marije Hofstra (UMC Utrecht) |
| 11:45 - 12:30 | SHM Monitoring Report presentation | Ard van Sighem (SHM) Ferdinand Wit (SHM) |
| Panel discussion: HIV in the Netherlands: have we reached the last mile? | Elske Hoornenborg (GGD Amsterdam) Kai Jonas (Maastricht University) Birgit van Benthem (RIVM) Jet Gisolf (Rijnstate) Hanna Bos (Soa Aids Nederland) Ard van Sighem (SHM) Ferdinand Wit (SHM) Moderator: Marc van der Valk (SHM, Amsterdam UMC) |
|
| 12:30-14:00 | Lunch & poster viewing | |
| SESSION 3 | Weighing in on cis- and transgender women, talking sex and eliminating HIV and HCV | |
| Chairs: Tania Mudrikova (UMC Utrecht) and Olivier Richel (Radboudumc) | ||
| 14:00-14:25 | Plenary: Immune and hormonal mechanisms of cardiometabolic risk in women living with HIV | Markella Zanni (Massachusetts General Hospital, Harvard University) |
| 14:25-14:40 | Moderated Q&A | |
| 14:40-14:50 | O.10: Reversibility of TAF- and/or INSTI-associated weight gain | Myrthe Verburgh (Amsterdam UMC) |
| 14:50-15:00 | O.11: Development of a sexual health-counselling program for HIV care providers during routine consultations; an Intervention Mapping approach | Suzanne de Munnik (Catharina Ziekenhuis) |
| 15:00-15:10 | O.12: Assessing the HIV care continuum among transgender women between 2010 and 2020 in the Netherlands: does HIV care engagement differ from that of men who have sex with men? | Elske Hoornenborg (GGD Amsterdam) |
| 15:10-15:20 | O.13: Elimination of the HIV-1 viral reservoir using DDX3 inhibitors | Jade Jansen (Amsterdam UMC) |
| 15:20-15:30 | O.14: Progress towards WHO HCV elimination incidence targets among people with HIV: findings from the International Collaboration on Hepatitis C Elimination in HIV Cohorts | Daniela van Santen (Burnet Institute Melbourne & GGD Amsterdam) |
| 15:30-16:00 | Refreshment break | |
| SESSION 4 | Protecting the Mind and the Body in HIV | |
| Chairs: Reina Foppen (Hiv Vereniging) and Peter Reiss | ||
| 16:00-16:25 | Plenary: Scalable mental health interventions for HIV: lessons from research in the Global North and South | Prof. Pamela Collins (UW Consortium for Global Mental Health, I-TECH, Seattle) |
| 16:25-16:40 | Moderated Q&A | |
| 16:40-16:50 | Presentation of Joep Lange & Jacqueline van Tongeren Junior Investigator’s Award | Board stichting NCHIV |
| 16:50-17:30 | Panel: Vaccination for people living with HIV: novel issues and implementation challenges | Moderator: Bram Goorhuis (Amsterdam UMC) Laura Laan (Amsterdam UMC) Anna Roukens (LUMC) Stella Zonneveld (Regional Association of General Practioners, ROHA) Reina Foppen (Hiv Vereniging) |
| Closing | Board stichting NCHIV | |
| 17:30 | Drinks | |
NCHIV is organised by
